Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
J Biol Chem
    October 2017
  1. DELIGIO JT, Lin G, Chalfant CE, Park MA, et al
    Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.
    J Biol Chem. 2017;292:17909-17918.
    >> Share

    July 2017
  2. LO PK, Zhang Y, Yao Y, Wolfson B, et al
    Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFbeta signaling.
    J Biol Chem. 2017;292:11466-11484.
    >> Share

    June 2017
  3. SANDERS MA, Haynes B, Nangia-Makker P, Polin LA, et al
    Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    J Biol Chem. 2017;292:10347-10363.
    >> Share

  4. TAN S, Ding K, Chong QY, Zhao J, et al
    Decreased miR26a/b and increased HuR expression post-transcriptionally upregulates ERBB2 to mediate acquired tamoxifen resistance in ER+ breast cancer cells.
    J Biol Chem. 2017 Jun 21. pii: jbc.M117.780973. doi: 10.1074/jbc.M117.780973.
    >> Share

    May 2017
  5. ROY A, Ansari SA, Das K, Prasad R, et al
    Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to beta-catenin accumulation via the AKT/GSK3beta pathway and contributes to breast cancer progression.
    J Biol Chem. 2017 May 18. pii: jbc.M116.764670. doi: 10.1074/jbc.M116.764670.
    >> Share

  6. MERCADO-MATOS J, Clark JL, Piper AJ, Janusis J, et al
    Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.
    J Biol Chem. 2017;292:7806-7816.
    >> Share

  7. KERROS C, Tripathi SC, Zha D, Mehrens JM, et al
    Neuropilin-1 mediates Neutrophil Elastase uptake and cross-presentation in breast cancer cells.
    J Biol Chem. 2017 May 3. pii: jbc.M116.773051. doi: 10.1074/jbc.M116.773051.
    >> Share

    April 2017
  8. CHEN J, De Raeymaecker J, Hovgaard JB, Smaardijk S, et al
    Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a).
    J Biol Chem. 2017;292:6938-6951.
    >> Share

  9. MAJKOWSKA I, Shitomi Y, Ito N, Gray NS, et al
    Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.
    J Biol Chem. 2017;292:6633-6643.
    >> Share

  10. JEONG J, VanHouten JN, Kim W, Dann P, et al
    The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
    J Biol Chem. 2017;292:6555-6568.
    >> Share

  11. CHOO M, Tan HL, Ding V, Castangia R, et al
    Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.
    J Biol Chem. 2017;292:6163-6176.
    >> Share

    March 2017
  12. OHOKA N, Okuhira K, Ito M, Nagai K, et al
    In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).
    J Biol Chem. 2017;292:4556-4570.
    >> Share

  13. YAMAGUCHI N, Nakayama Y, Yamaguchi N
    Down-regulation of Forkhead Box Protein A1 (FOXA1) Leads to Cancer-stem Cell-like Properties in Tamoxifen-resistant Breast Cancer Cells through Induction of Interleukin-6.
    J Biol Chem. 2017 Mar 7. pii: jbc.M116.763276. doi: 10.1074/jbc.M116.763276.
    >> Share

    February 2017
  14. NAKANO M, Fukami T, Gotoh S, Nakajima M, et al
    A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    J Biol Chem. 2017 Feb 10. pii: jbc.M117.775684. doi: 10.1074/jbc.M117.775684.
    >> Share

    December 2016
  15. SCHAUWECKER SM, Kim JJ, Licht JD, Clevenger CV, et al
    Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-Induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.
    J Biol Chem. 2016 Dec 29. pii: jbc.M116.764233. doi: 10.1074/jbc.M116.764233.
    >> Share

    November 2016
  16. ALEXANDER PB, Chen R, Gong C, Yuan L, et al
    Distinct receptor tyrosine kinase subsets mediate anti-HER2 drug resistance in breast cancer.
    J Biol Chem. 2016 Nov 30. pii: jbc.M116.754960.
    >> Share

  17. FANCY RM, Wang L, Schmid T, Zeng Q, et al
    Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
    J Biol Chem. 2016;291:23489.
    >> Share

  18. KO YH, Domingo-Vidal M, Roche M, Lin Z, et al
    TIGAR Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    J Biol Chem. 2016 Nov 1. pii: jbc.M116.740209.
    >> Share

    October 2016
  19. ZHAO JJ, Lin J, Yang H, Kong W, et al
    MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.
    J Biol Chem. 2016;291:22859.
    >> Share

  20. GUO JP, Shu SK, Esposito NN, Coppola D, et al
    IKK phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.
    J Biol Chem. 2016;291:22857.
    >> Share

  21. KONG W, He L, Coppola M, Guo J, et al
    MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
    J Biol Chem. 2016;291:22855.
    >> Share

  22. CHANMEE T, Ontong P, Izumikawa T, Higashide M, et al
    Hyaluronan production regulates metabolic and cancer stem-like properties of breast cancer cells via hexosamine biosynthetic pathway-coupled HIF-1 signaling.
    J Biol Chem. 2016 Oct 6. pii: jbc.M116.751263.
    >> Share

    September 2016
  23. BEZAWORK-GELETA A, Dong L, Rohlena J, Neuzil J, et al
    The assembly factor SDHAF2 is dispensable for flavination of the catalytic subunit of mitochondrial complex II in breast cancer cells.
    J Biol Chem. 2016 Sep 1. pii: jbc.C116.755017.
    >> Share

    August 2016
  24. QIAO Y, He H, Jonsson P, Sinha I, et al
    AP-1 is a key regulator of proinflammatory cytokine TNFalpha-mediated triple-negative breast cancer progression.
    J Biol Chem. 2016;291:18309.
    >> Share

  25. DUKEL M, Streitfeld WS, Tang TC, Backman LR, et al
    The Breast Cancer Tumor Suppressor TRIM29 is Expressed via ATM-Dependent Signaling in Response to Hypoxia.
    J Biol Chem. 2016 Aug 17. pii: jbc.M116.730960.
    >> Share

  26. HARRINGTON KM, Clevenger CV
    Identification of NEK3 Threonine 165 as a Novel Regulatory Phosphorylation Site that Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
    J Biol Chem. 2016 Aug 3. pii: jbc.M116.726190.
    >> Share

    July 2016
  27. BOATENG LR, Bennin D, De Oliveira S, Huttenlocher A, et al
    Mammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell Invasion.
    J Biol Chem. 2016;291:13987-98.
    >> Share

    June 2016
  28. LIU HJ, Ooms LM, Srijakotre N, Man J, et al
    PREX1 Rac-GEF Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular-Signal-Regulated Kinase 1/2 (ERK1/2) Signaling.
    J Biol Chem. 2016 Jun 29. pii: jbc.M116.743401.
    >> Share

    May 2016
  29. COKE CJ, Scarlett KA, Chetram MA, Jones KJ, et al
    Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.
    J Biol Chem. 2016;291:9991-10005.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016